SCHEMBL12366275

SCHEMBL12366275

[C-]#[N+]c1c(C(F)(F)F)cc(-c2ccccc2)n(Cc2ccc(C(F)(F)F)cc2)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.42
GLO1 Q04760 1/20 0.39
CNR1 P21554 1/20 0.39
DCTPP1 Q9H773 1/20 0.39
CLPP Q16740 1/20 0.39
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
FABP4 P15090 2/20 0.37
CHRM5 P08912 1/20 0.37
RXRA P19793 1/20 0.37
NR1H2 P55055 1/20 0.37
NR1H3 Q13133 1/20 0.37
P2RX3 P56373 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
PPARG P37231 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12366238 0.93 DCTPP1 (0.42) CFTRGLO1CNR1DCTPP1KDM4E
SCHEMBL12366212 0.93 CNR1 (0.44) CFTRCNR1DCTPP1KDM4EHPGD
SCHEMBL12366487 0.92 CNR1 (0.39) CFTRCNR1DCTPP1KDM4EHPGD
SCHEMBL12366320 0.91 KDM4E (0.47) CNR1DCTPP1KDM4EHPGDNPSR1
SCHEMBL12366308 0.91 RXRA (0.43) CNR1DCTPP1KDM4EHPGDRXRA
SCHEMBL12366313 0.90 CNR1 (0.38) CFTRCNR1DCTPP1CLPPKDM4E
SCHEMBL12366359 0.90 PKN1 (0.43) CFTRCNR1DCTPP1CLPPKDM4E
SCHEMBL12366245 0.90 CNR1 (0.43) CNR1DCTPP1KDM4EHPGDNPSR1
SCHEMBL12366226 0.89 RGS4 (0.43) CFTRCNR1RGS4RGS8
SCHEMBL12366278 0.89 MAPT (0.45) KDM4EFABP4PPARGCA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed